MoneyWorks4Me

Concord Drugs informs about board meeting

19 May 2016 Evaluate

Concord Drugs has informed that the meeting of the Board of Directors of the Company will be held on May 30, 2016, to consider the Audited financial results for the quarter and year ended 31.03.2016, Audit Report for the Quarter and Year ended 31.03.2016, and Appointment of Secretarial auditor for the year 2016-17.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..